# OnCo record citius-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/citius-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "citius-pharmaceuticals" ;
  schema:name "Citius Pharmaceuticals"@en ;
  schema:description "Citius Pharmaceuticals brought denileukin diftitox back to market as Lymphir, approved in 2024 for relapsed cutaneous T-cell lymphoma, through its Citius Oncology subsidiary."@en ;
  schema:url <https://onco.cc/companies/citius-pharmaceuticals/>, <https://www.citiuspharma.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.citiuspharma.com> ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/denileukin-diftitox/> ;
  onco:companies <https://onco.cc/companies/eisai/> .